Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients-Reference-Cited by-同舟云学术

Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients

Published:2021-02 Issue:2 Volume:39 Page:130.e17-130.e24
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Sun Maxine,Marchese Maya,Friedlander David F.,Nguyen David-Dan,Cole Alexander P.,Fletcher Sean A.,Mahal Brandon A.,Nguyen Paul L.,Choueiri Toni K.,Kibel Adam S.,Trinh Quoc-Dien

Funder

American Urological Association Foundation

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Projections of the cost of cancer care in the United States: 2010-2020;Mariotto;J Natl Cancer Inst,2011

2. Evaluation of trends in the cost of initial cancer treatment;Warren;J Natl Cancer Inst,2008

3. Future cancer incidence in the US: burdens upon an aging, changing nation;Smith;J Clin Oncol,2009

4. High-cost users of medical care;Zook;N Engl J Med,1980

5. Total Medicare costs associated with diagnosis and treatment of prostate cancer in elderly men;Trogdon;JAMA Oncol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Descriptive analysis of prostate cancer pathology data from diagnosis and surgery in men from the 45 and Up Study;Pathology;2024-02

2. The Care Apparatus and Healthcare Professionals at Work;Prostate Cancer, Sexual Health, and Ageing Masculinities;2024

3. Prostate Cancer Prediction Using Healthcare Utilization Patterns;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05

4. Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study;European Urology;2021-10